SUPN
Price:
$33.84
Market Cap:
$1.86B
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise Qelbree, a selective norepinephrine reuptake inhibitor indicated for the treatment of attention-deficit hy...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-05-01
Stock Exchange
NASDAQ
Ticker
SUPN
According to Supernus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 376.00. This represents a change of -62.72% compared to the average of 1.01K of the last 4 quarters.
The mean historical PE Ratio of Supernus Pharmaceuticals, Inc. over the last ten years is 140.90. The current 376.00 PE Ratio has changed 26.59% with respect to the historical average. Over the past ten years (40 quarters), SUPN's PE Ratio was at its highest in in the March 2024 quarter at 3.70K. The PE Ratio was at its lowest in in the June 2023 quarter at -492.89.
Average
140.90
Median
23.32
Minimum
10.43
Maximum
1.20K
Discovering the peaks and valleys of Supernus Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.70%
Maximum Annual PE Ratio = 1.20K
Minimum Annual Increase = -778.93%
Minimum Annual PE Ratio = 10.43
Year | PE Ratio | Change |
---|---|---|
2023 | 1.20K | 3.70% |
2022 | 31.53 | 8.79% |
2021 | 28.98 | 177.94% |
2020 | 10.43 | -5.17% |
2019 | 11.00 | -29.33% |
2018 | 15.56 | -55.93% |
2017 | 35.31 | 157.84% |
2016 | 13.69 | -69.93% |
2015 | 45.53 | 157.95% |
2014 | 17.65 | -778.93% |
The current PE Ratio of Supernus Pharmaceuticals, Inc. (SUPN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
419.94
5-year avg
256.25
10-year avg
140.90
Supernus Pharmaceuticals, Inc.’s PE Ratio is greater than Prestige Consumer Healthcare Inc. (18.08), greater than Evotec SE (-3.15), greater than Collegium Pharmaceutical, Inc. (12.07), greater than Deciphera Pharmaceuticals, Inc. (-11.74), greater than Eagle Pharmaceuticals, Inc. (5.10), greater than ANI Pharmaceuticals, Inc. (43.28), greater than Phibro Animal Health Corporation (324.20), greater than Pacira BioSciences, Inc. (10.06), greater than Dr. Reddy's Laboratories Limited (19.95), greater than Silver Spike Investment Corp. (14.29), greater than Regencell Bioscience Holdings Limited (-18.48),
Company | PE Ratio | Market cap |
---|---|---|
18.08 | $3.68B | |
-3.15 | $1.19B | |
12.07 | $1.20B | |
-11.74 | $2.21B | |
5.10 | $55.19M | |
43.28 | $1.27B | |
324.20 | $788.20M | |
10.06 | $638.86M | |
19.95 | $13.19B | |
14.29 | $71.22M | |
-18.48 | $87.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Supernus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Supernus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Supernus Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Supernus Pharmaceuticals, Inc. (SUPN)?
What is the highest PE Ratio for Supernus Pharmaceuticals, Inc. (SUPN)?
What is the 3-year average PE Ratio for Supernus Pharmaceuticals, Inc. (SUPN)?
What is the 5-year average PE Ratio for Supernus Pharmaceuticals, Inc. (SUPN)?
How does the current PE Ratio for Supernus Pharmaceuticals, Inc. (SUPN) compare to its historical average?